Organogenesis Holdings

Organogenesis Holdings

ORGO· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +61.9% in FY2025

Gary S. Gillheeney, Sr. is the CEO of Organogenesis Holdings and was paid $6.8M in FY2025 (Dec), down 3%.

Pay$100 in the stock at the end of FY20 → $69
CEO pay is from each Organogenesis Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Gary S. Gillheeney, Sr.FY2025
  2. 2Brian GrowFY2025
  3. 3Patrick BilboFY2025
  4. 4Lori FreedmanFY2025
  5. 5David FranciscoFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Organogenesis Holdings paid its 5 named executives $15.1M in total in FY2025 (Dec). CEO Gary S. Gillheeney, Sr. was paid $6.8M of that.

Name
Gary S. Gillheeney, Sr.President and Chief Executive Officer; Principal Executive Officer
Brian GrowChief Commercial OfficerNot disclosed
Patrick BilboChief Operating Officer
Lori FreedmanChief Administrative and Legal Officer
David FranciscoChief Financial Officer; Principal Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers20

See all

The FY2025 (Dec) proxy of Organogenesis Holdings names 20 peer companies for pay. Among Organogenesis Holdings and these peers, CEO pay was 9th highest of 13 and total shareholder return was 6th highest of 13.

9th highest of 13in Organogenesis Holdings and its pay peers, FY2025 (Dec) by CEO pay:

$3.5M$10.3M

6th highest of 13in Organogenesis Holdings and its pay peers, FY2025 (Dec) by total shareholder return:

$19$193

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board2

See all
  • Jon GiacominDirector · 4 yr on the boardIndependentAudit, Compensation, Nominating (Chair)—Paid as an executive
  • Michael J. DriscollDirector · 3 yr on the boardIndependentAudit, Nominating—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    Organogenesis Holdings COO pay rose 11% to $1.5M. The stock fell 71% in FY2022 (Dec).
    DEF 14A
  2. Pay
    Organogenesis Holdings General counsel pay rose 14% to $1.2M. The stock fell 71% in FY2022 (Dec).
    DEF 14A
  3. Pay
    Organogenesis Holdings CEO pay rose 12% to $7.0M. The stock fell 22% in FY2024 (Dec).
    DEF 14A
  4. Pay
    Organogenesis Holdings CEO pay rose 36% to $6.0M. The stock fell 71% in FY2022 (Dec).
    DEF 14A
  5. Pay
    Organogenesis Holdings CFO pay rose 24% to $2.0M. The stock fell 22% in FY2024 (Dec).
    DEF 14A
  6. Pay
    Organogenesis Holdings CFO pay fell 17% to $1.2M. The stock fell 71% in FY2022 (Dec).
    DEF 14A
  7. Pay
    Organogenesis Holdings COO pay rose 47% to $2.2M. The stock rose 52% in FY2023 (Dec).
    DEF 14A
  8. Pay
    Organogenesis Holdings General counsel pay rose 62% to $2.0M. The stock rose 52% in FY2023 (Dec).
    DEF 14A
  9. Pay
    Organogenesis Holdings CFO pay rose 37% to $1.6M. The stock rose 52% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AMay 12, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KFeb 29, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data